Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells [Oncotarget, 7, 8, (2016) (9135-9149)] DOI: 10.18632/oncotarget.7035

Chun Yu Liu, Ming Hung Hu, Chia Jung Hsu, Chun Teng Huang, Duen Shian Wang, Wen Chun Tsai, Yi Ting Chen, Chia Han Lee, Pei Yi Chu, Chia Chi Hsu, Ming Huang Chen, Chung Wai Shiau, Ling Ming Tseng, Kuen Feng Chen

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Present: Due to an error during figure assembly, the center panel of Figure 2B was prepared using the wrong set of blots. Corrected: The corrected Figure 2 is shown below. The authors sincerely apologize for this oversight.

Original languageEnglish
Pages (from-to)10760
Number of pages1
JournalOncotarget
Volume8
Issue number6
DOIs
Publication statusPublished - 2017

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells [Oncotarget, 7, 8, (2016) (9135-9149)] DOI: 10.18632/oncotarget.7035'. Together they form a unique fingerprint.

Cite this